Rapport Therapeutics initiated with a Buy at JonesResearch
PremiumThe FlyRapport Therapeutics initiated with a Buy at JonesResearch
1M ago
Rapport Therapeutics sees cash runway through end of 2026
Premium
The Fly
Rapport Therapeutics sees cash runway through end of 2026
3M ago
Rapport Therapeutics reports Q2 EPS ($1.70), consensus (67c)
Premium
The Fly
Rapport Therapeutics reports Q2 EPS ($1.70), consensus (67c)
3M ago
Rapport Therapeutics initiated with a Buy at Jefferies
PremiumThe FlyRapport Therapeutics initiated with a Buy at Jefferies
5M ago
Rapport Therapeutics initiaetd with a Not Rated at Goldman Sachs
Premium
The Fly
Rapport Therapeutics initiaetd with a Not Rated at Goldman Sachs
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100